Retraction notice to “In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma” [Life Sciences 285 (2021) 119961]

Life Sciences 2026

View at publisher

Authors: Ahmed M. Mamdouh, Dina M. Khodeer, Mohamed A. Tantawy, Yasser M. Moustafa

DOI: 10.1016/j.lfs.2026.124268

Cited by: 0

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Metabolism Diabetes and Cancer Drug Transport and Resistance Mechanisms